Introduction:

Stem Cell Banking Market accounted for US$ 6.3 Billion in 2024 and is estimated to be US$ 16.3 Billion by 2034 and is anticipated to register a CAGR of 11.0%.

Stem cells are the highly specialized body cells working as a foundation cells for organ and tissue in the body. The birth of child is the only chance to collect as well as store these stem cells which can be used to treat various diseases. The stem cells have ability to rebuild or regenerate themselves. Stem cells are also known as building blocks of the immune system and blood, as they help to repair tissues, organs, and blood vessels. Stem cells found in umbilical cord blood which have been used in treating disease like sickle cell disease, leukemia, multiple myeloma, lymph proliferative disorders, and SCID. 

Growing awareness regarding therapeutic potential of stem cells

Growing awareness regarding therapeutic potential of stem cells is key factor driving growth of the stem cell banking market. Additionally, growing developments of novel technologies for stem cell preservation, processing, and storage is supporting factor propelling growth of the target market.

Rising hematopoietic stem cell transplantation procedures, coupled with increasing investments in stem cell-based research are major factors expected to fuel growth of the stem cell banking market over the forecast period. However, a high cost of stem cell banking is key factor for restraining growth of the stem cell banking market.

Stem cell banking market is segmented on the basis of source type, service type, application, and region.

On the basis of source type, the stem cell banking market is segmented into cord blood and cord tissue. On the basis of service type, the target market is classified into collection and transportation, processing, analysis, and storage. On the basis of application, the stem cell banking market is bifurcated into leukemia, diabetes lymphoma, cerebral palsy, thalassemia, and others.

Regional Insights:

Stem Cell Banking Market accounted for US$ 10.54 billion in 2020 and is estimated to be US$ 21.67 billion by 2030 and is anticipated to register a CAGR of 7.50%. On the basis of region, the stem cell banking market has been segmented into North America, Europe, Asia Pacific, Latin America, Middle East, and Africa. Each of these regions is analyzed on the basis of market findings across major countries in these regions for a macro-level understanding of the global market. The market in North America is expected to account for major revenue share in the global market as compared to that of other regions. This can be attributed to availability of federal funding for stem cell research and rise in preference of private stem cell banking in the countries of the region. Also, the market in Europe is expected to account for second-highest revenue share in the global market, followed by the market in Asia Pacific.

Attribute	Details
Base year for estimation	2023
Forecast period	2024 – 2034
Market representation	Revenue in USD Million & CAGR from 2024 – 2034
Market Segmentation	By Source Type - Cord Blood and Cord Tissue By Service Type – Collection and Transportation, Processing, Analysis, and Storage By Application – Leukemia, Diabetes, Lymphoma, Cerebral Palsy, Thalassemia, and Others
Regional scope	North America - U.S., Canada Europe - UK, Germany, Spain, France, Italy, Russia, Rest of Europe Asia Pacific - Japan, India, China, South Korea, Australia, Rest of Asia-Pacific Latin America - Brazil, Mexico, Argentina, Rest of Latin America Middle East & Africa - South Africa, Saudi Arabia, UAE, Rest of Middle East & Africa
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends

Segments Covered in the Report:

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends and opportunities in each of the sub-segments from 2019 to 2029. For the purpose of this study, has segmented the stem cell banking market report based on Source Type, Service Type, End User and Region.

 

Key players operating in the stem cell banking market includes Cryo-cell International, Inc., Stem Cyte, Inc., ViaCord, Inc., Cord Blood Registry , Inc., SmartCells, Inc., LifeCell International Pvt.Ltd, Cryoviva Biotech Pvt. Ltd., Cryo Stemcel Private Limited, Reliance Life Sciences Private Limited, and Trascell Biolife Pvt. Ltd.

Recent Development:

 The New Launched Product News,

• In July 2023, Cell Genesis announced the launch of CEXCI Cord Protein Banking, a groundbreaking initiative that marks a new era in the field of stem cell research and personalized medicine. This innovative approach harnesses the power of umbilical cord stem cells protein to unlock a world of possibilities for improved health outcomes and transformative medical treatments.
• In November 2023, LifeCell, India's largest and most accredited stem cell banking company announced the launch of world's most affordable stem cell banking solution. Aishwarya Rai Bachchan, a patron of LifeCell and goodwill ambassador for stem cell banking reinforced the value of stem cell banking on the occasion of 25th anniversary year of stem cell treatments and stated this as the best gift parents can give for their child.

• CDI laboratories
  • Company Overview
  • Product Portfolio
  • Key Highlights
  • Financial Performance
• Cryo-cell International
  • Company Overview
  • Product Portfolio
  • Key Highlights
  • Financial Overview
• Stem Cyte, Inc.
  • Company Overview
  • Product Portfolio
  • Key Highlights
  • Financial Performance
• ViaCord
  • Company Overview
  • Product Portfolio
  • Key Highlights
  • Financial Performance
• Cord Blood Registry
  • Company Overview
  • Product Portfolio
  • Key Highlights
  • Financial Performance
• SmartCells, Inc.
  • Company Overview
  • Product Portfolio
  • Key Highlights
  • Financial Performance
• LifeCell International Pvt.Ltd
  • Company Overview
  • Product Portfolio
  • Key Highlights
  • Financial Performance
• Cryoviva Biotech Pvt. Ltd
  • Company Overview
  • Product Portfolio
  • Key Highlights
  • Financial Performance
• Cryo Stemcell
  • Company Overview
  • Product Portfolio
  • Key Highlights
  • Financial Performance
• Reliance Life Sciences
  • Company Overview
  • Product Portfolio
  • Key Highlights
  • Financial Performance
• Trascell Biolife Pvt. Ltd.
  • Company Overview
  • Product Portfolio
  • Key Highlights
  • Financial Performance

1. Research Objective and Assumption
   • Preface
   • Research Objectives
   • Study Scope
   • Years Considered for the study
   • Assumptions
   • Abbreviations
2. Research Methodology
   • Research data
   • Primary Data
     • Primary Interviews
     • Primary Breakdown
     • Key data from Primary Sources
     • Key Thickness Insights
   • Secondary Data
     • Major Secondary Sources
     • Secondary Sources
   • Market Estimation
   • Top-Down Approach
     • Approach for estimating Market Share by Top-Down Analysis (Supply Side)
   • Bottom-Up Approach
     • Approach for estimating market share by Bottom-up Analysis (Demand Side)
   • Market Breakdown and Data Triangulation
   • Research Assumptions
3. Market Preview
   • Executive Summary
   • Key Findings—Global Outlook for medical carts Strategies
     • Key Questions this Study will Answer
     • Market Snippet, By Source Type
     • Market Snippet, By Service Type
     • Market Snippet, By Application
     • Market Snippet, By Region
   • Opportunity Map Analysis
   • Executive Summary—3 Big Predictions
4. Market Dynamics, Regulations, and Trends Analysis
   • Market Dynamics
     • Drivers
     • Restrains
     • Market Opportunities
     • Market Trends
   • DR Impact Analysis
   • PEST Analysis
   • Porter’s Five Forces Analysis
   • Opportunity Orbit
   • Market Investment Feasibility Index
   • Macroeconomic Factor Analysis
5. Market Segmentation, By Source Type, Forecast Period up to 10 Years, (US$ Bn)

• Overview
  • Market Value and Forecast (US$ Bn), and Share Analysis (%), Forecast Period up to 10 Years
  • Y-o-Y Growth Analysis (%), Forecast Period up to 10 Years
  • Segment Trends
• Cord Blood
  • Overview
  • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
• Cord Tissue
  • Overview
  • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years

Market Segmentation, By Service Type, Forecast Period up to 10 Years, (US$ Bn)

• Overview
  • Market Value and Forecast (US$ Bn), and Share Analysis (%), Forecast Period up to 10 Years
  • Y-o-Y Growth Analysis (%), Forecast Period up to 10 Years
  • Segment Trends
• Collection
  • Overview
  • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
• Transportation
  • Overview
  • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
• Processing
  • Overview
  • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
• Analysis
  • Overview
  • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
• Storage
  • Overview
  • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years

Market Segmentation, By Application, Forecast Period up to 10 Years, (US$ Bn)

• Overview
  • Market Value and Forecast (US$ Bn), and Share Analysis (%), Forecast Period up to 10 Years
  • Y-o-Y Growth Analysis (%), Forecast Period up to 10 Years
  • Segment Trends
• Leukemia
  • Overview
  • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
• Diabetes
  • Overview
  • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
• Lymphoma
  • Overview
  • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
• Cerebral Palsy
  • Overview
  • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
• Thalassemia
  • Overview
  • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
• Others
  • Overview
  • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years

Global Market, By Region, Forecast Period up to 10 Years, (US$ Bn)

• Overview
  • Market Value and Forecast (US$ Bn), and Share Analysis (%), Forecast Period up to 10 Years
  • Y-o-Y Growth Analysis (%), Forecast Period up to 10 Years
  • Regional Trends
• North America
  • Market Size and Forecast (US$ Bn), By Source Type, Forecast Period up to 10 Years
  • Market Size and Forecast (US$ Bn), By Service Type, Forecast Period up to 10 Years
  • Market Size and Forecast (US$ Bn), By End User Type, Forecast Period up to 10 Years
  • Market Size and Forecast (US$ Bn), By End-Users , Forecast Period up to 10 Years
  • Market Size and Forecast (US$ Bn), By Country, Forecast Period up to 10 Years
    • U.S.
    • Canada
• Europe
  • Market Size and Forecast (US$ Bn), By Source Type, Forecast Period up to 10 Years
  • Market Size and Forecast (US$ Bn), By Service Type, Forecast Period up to 10 Years
  • Market Size and Forecast (US$ Bn), By End User Type, Forecast Period up to 10 Years
  • Market Size and Forecast (US$ Bn), By End-Users , Forecast Period up to 10 Years
  • Market Size and Forecast (US$ Bn), By Country, Forecast Period up to 10 Years
    • UK
    • France
    • Germany
    • Russia
    • Italy
    • Rest of Europe
• Asia Pacific
  • Market Size and Forecast (US$ Bn), By Source Type, Forecast Period up to 10 Years
  • Market Size and Forecast (US$ Bn), By Service Type, Forecast Period up to 10 Years
  • Market Size and Forecast (US$ Bn), By End User Type, Forecast Period up to 10 Years
  • Market Size and Forecast (US$ Bn), By End-Users , Forecast Period up to 10 Years
  • Market Size and Forecast (US$ Bn), By Country, Forecast Period up to 10 Years
    • India
    • Japan
    • South Korea
    • China
    • Rest of Asia Pacific

• Latin America
  • Market Size and Forecast (US$ Bn), By Source Type, Forecast Period up to 10 Years
  • Market Size and Forecast (US$ Bn), By Service Type, Forecast Period up to 10 Years
  • Market Size and Forecast (US$ Bn), By End User Type, Forecast Period up to 10 Years
  • Market Size and Forecast (US$ Bn), By End-Users , Forecast Period up to 10 Years
  • Market Size and Forecast (US$ Bn), By Country, Forecast Period up to 10 Years

• Brazil
• Mexico
• Rest of Latin America
• Middle East & Africa
  • Market Size and Forecast (US$ Bn), By Source Type, Forecast Period up to 10 Years
  • Market Size and Forecast (US$ Bn), By Service Type, Forecast Period up to 10 Years
  • Market Size and Forecast (US$ Bn), By End User Type, Forecast Period up to 10 Years
  • Market Size and Forecast (US$ Bn), By End-Users , Forecast Period up to 10 Years
  • Market Size and Forecast (US$ Bn), By Country, Forecast Period up to 10 Years

• GCC
• Israel
• South Africa
• Rest of Middle East

1. Competitive Landscape
   • Heat Map Analysis
   • Market Presence and Specificity Analysis
2. Company Profiles

• Cryo-cell International, Inc
  • Company Overview
  • Product Portfolio
  • Key Highlights
  • Financial Overview
  • Business Strategies
• Stem Cyte, Inc
  • Company Overview
  • Product Portfolio
  • Key Highlights
  • Financial Overview
  • Business Strategies
• ViaCord, Inc
  • Company Overview
  • Product Portfolio
  • Key Highlights
  • Financial Overview
  • Business Strategies
• Cord Blood Registry
  • Company Overview
  • Product Portfolio
  • Key Highlights
  • Financial Overview
  • Business Strategies
• SmartCells, Inc
  • Company Overview
  • Product Portfolio
  • Key Highlights
  • Financial Overview
  • Business Strategies
• LifeCell International Pvt.Ltd
  • Company Overview
  • Product Portfolio
  • Key Highlights
  • Financial Overview
  • Business Strategies
• Cryoviva Biotech Pvt. Ltd
  • Company Overview
  • Product Portfolio
  • Key Highlights
  • Financial Overview
  • Business Strategies
• Cryo StemcelPrivate Limited
  • Company Overview
  • Product Portfolio
  • Key Highlights
  • Financial Overview
  • Business Strategies
• Reliance Life Sciences Private Limited
  • Company Overview
  • Product Portfolio
  • Key Highlights
  • Financial Overview
  • Business Strategies
• Trascell Biolife Pvt. Ltd
  • Company Overview
  • Product Portfolio
  • Key Highlights
  • Financial Overview
  • Business Strategies

The Last Word

• Future Impact
• About Us
• Contact